|
SNOMED_concept_description
|
SNOMED_concept_description |
|
|
Patient_Readmission
|
Patient_Readmission |
|
|
arachidonic_acid
|
arachidonic_acid |
|
|
|Disorder of cardiovascular system (disorder)|
|
49601007 |
|
|
Nivolumab
|
Nivolumab |
|
|
Receiving_radiotherapy
|
Receiving_radiotherapy |
|
|
Large or small intestine
|
181254001 |
|
|
Psychotic disorder
|
69322001 |
|
|
motor_neuron_disease
|
motor_neuron_disease |
|
|
No_contacts
|
No_contacts |
|
|
antitussive
|
antitussive |
|
|
Triacylglycerol_lipase:CCnc:Pt:Body_fld:Qn
|
Triacylglycerol_lipase:CCnc:Pt:Body_fld:Qn |
|
|
Million_per_Microliter
|
Million_per_Microliter |
|
|
Lost_To_Follow-Up
|
Lost_To_Follow-Up |
|
|
Do_I_become_short_of_breath_when_speaking
|
Do_I_become_short_of_breath_when_speaking |
|
|
Personal history of COVID-19
|
Z86.16 |
[cov-19 history] |
|
Ribavirin
|
J05AP01 |
|
|
Porphobilinogen_Measurement
|
Porphobilinogen_Measurement |
|
|
General_Surgery
|
General_Surgery |
|
|
Peripheral oxygen saturation (observable entity)
|
431314004 |
|
